Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Chimeric Therapeutics Ltd. ( (AU:CHM) ).
Chimeric Therapeutics Ltd. has announced a placement offer to raise up to $6.6 million through the issuance of up to 1.65 billion placement shares at $0.004 per share. The offer includes attaching options and contingent options for subscribers, along with adviser options for joint lead managers. This strategic financial move is aimed at strengthening the company’s capital base, potentially enhancing its operational capabilities and market positioning.
More about Chimeric Therapeutics Ltd.
Chimeric Therapeutics Ltd. operates in the biotechnology industry, focusing on the development of innovative therapies. The company is primarily engaged in the research and development of advanced therapeutic solutions, with a market focus on leveraging cutting-edge biotechnology to address unmet medical needs.
Technical Sentiment Signal: Sell
Current Market Cap: A$7.4M
See more data about CHM stock on TipRanks’ Stock Analysis page.